Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma

BACKGROUND: TP53 mutation is the most common mutation in hepatocellular carcinoma (HCC), and it affects the progression and prognosis of HCC. We investigated how TP53 mutation regulates the HCC immunophenotype and thus affects the prognosis of HCC. METHODS: We investigated TP53 mutation status and R...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EBioMedicine
Auteurs principaux: Long, Junyu, Wang, Anqiang, Bai, Yi, Lin, Jianzhen, Yang, Xu, Wang, Dongxu, Yang, Xiaobo, Jiang, Yan, Zhao, Haitao
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019
Sujets:
Research paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491941/
https://ncbi.nlm.nih.gov/pubmed/30885723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.03.022
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires